Pancreatitis and gallbladder disease, though uncommon, are recognised risks associated with GLP-1 receptor agonist use, as documented in the Summary of Product Characteristics (SmPC) for licensed agents in this class (such as semaglutide)
Pan K-L, Hsu Y-C, Chang S-T, Chung C-M, Lin C-L
GHK-Cu, a copper-binding peptide, also plays a role in tissue repair
Support in Worcester In Worcester, Neighbourhood Mental Health Teams provides comprehensive mental health support for Wegovy patients
Weighed down by stigma: How weight-based social identity threat contributes to weight gain and poor health
Patients using semaglutide have shown improvements in various metabolic markers, including reduced blood sugar levels and lower blood pressure, which are crucial for individuals with type 2 diabetes or metabolic syndrome